cancer treatment

LuciLaro is a targeted cancer therapy used for tumors with NTRK gene fusions. It is suitable for both adult and pediatric patients with solid tumors. Active Ingredient Larotrectinib is a TRK inhibitor that blocks abnormal TRK fusion proteins driving cancer growth. Uses of LuciLaro • NTRK fusion-positive solid tumors • Advanced or metastatic cancers How LuciLaro Works It selectively inhibits TRK proteins, stopping tumor cell proliferation. How to Use LuciLaro • Take as prescribed • Can be taken with or without food Possible Side Effects • Fatigue • Dizziness • Nausea Precautions • Monitor liver function • Avoid pregnancy Safety Information Regular follow-up is required for safe use. Storage • Store at room temperature • Keep away from moisture • Keep out of reach of children